Literature DB >> 9359552

Beta-blocker prevention of proarrhythmia and proischemia: clues from CAST, CAMIAT, and EMIAT. Cardiac Arrhythmia Suppression Trial. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. European Myocardial Infarct Amiodarone Trial.

H L Kennedy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9359552     DOI： 10.1016/s0002-9149(97)00675-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  5 in total

Review 1.  Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.

Authors:  Kristin E Ellison; Gaurang Gandhi
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Can antiarrhythmic agents be selected based on mechanism of action?

Authors:  W Lau; D Newman; P Dorian
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 3.  Prevention of and medical therapy for atrial arrhythmias in heart failure.

Authors:  A U Khand; J G F Cleland; P C Deedwania
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

Review 4.  [Perioperative cardioprotection. Golden standard beta-blockade?].

Authors:  Nils Butte; B W Böttiger; P Teschendorf
Journal:  Anaesthesist       Date:  2007-03       Impact factor: 1.041

Review 5.  Review of nifedipine GITS in the treatment of high risk patients with coronary artery disease and hypertension.

Authors:  Amber Lundy; Nahla Lutfi; Cherylyn Beckey
Journal:  Vasc Health Risk Manag       Date:  2009
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.